RhumbLine Advisers’s Mustang Bio MBIO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-1
| Closed | -$285 | – | 4341 |
|
2023
Q2 | $285 | Buy |
+1
| New | +$285 | ﹤0.01% | 4343 |
|
2022
Q2 | – | Sell |
-95
| Closed | -$72K | – | 3179 |
|
2022
Q1 | $72K | Sell |
95
-12
| -11% | -$9.1K | ﹤0.01% | 2943 |
|
2021
Q4 | $133K | Buy |
107
+5
| +5% | +$6.22K | ﹤0.01% | 2906 |
|
2021
Q3 | $205K | Buy |
102
+3
| +3% | +$6.03K | ﹤0.01% | 2909 |
|
2021
Q2 | $246K | Buy |
99
+53
| +115% | +$132K | ﹤0.01% | 2864 |
|
2021
Q1 | $115K | Buy |
46
+2
| +5% | +$5K | ﹤0.01% | 2920 |
|
2020
Q4 | $124K | Buy |
44
+9
| +26% | +$25.4K | ﹤0.01% | 2941 |
|
2020
Q3 | $83K | Sell |
35
-7
| -17% | -$16.6K | ﹤0.01% | 2901 |
|
2020
Q2 | $100K | Buy |
42
+3
| +8% | +$7.14K | ﹤0.01% | 2967 |
|
2020
Q1 | $79K | Hold |
39
| – | – | ﹤0.01% | 2816 |
|
2019
Q4 | $120K | Buy |
39
+1
| +3% | +$3.08K | ﹤0.01% | 2855 |
|
2019
Q3 | $93K | Hold |
38
| – | – | ﹤0.01% | 2896 |
|
2019
Q2 | $106K | Buy |
38
+12
| +46% | +$33.5K | ﹤0.01% | 2921 |
|
2019
Q1 | $66K | Hold |
26
| – | – | ﹤0.01% | 2902 |
|
2018
Q4 | $58K | Buy |
26
+8
| +44% | +$17.8K | ﹤0.01% | 2931 |
|
2018
Q3 | $79K | Sell |
18
-1
| -5% | -$4.39K | ﹤0.01% | 2887 |
|
2018
Q2 | $99K | Buy |
+19
| New | +$99K | ﹤0.01% | 2872 |
|